Erfassung regionaler und systemischer Toxizität der isolierten, hyperthermen Extremitätenperfusion mit Tumor-Nekrose-Faktor alpha und Melphalan

Standard

Erfassung regionaler und systemischer Toxizität der isolierten, hyperthermen Extremitätenperfusion mit Tumor-Nekrose-Faktor alpha und Melphalan. / Hohenberger, P; Haier, J; Kettelhack, C; Schulze, G; Schlag, P M.

in: CHIRURG, Jahrgang 68, Nr. 9, 09.1997, S. 914-20.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Hohenberger, P, Haier, J, Kettelhack, C, Schulze, G & Schlag, PM 1997, 'Erfassung regionaler und systemischer Toxizität der isolierten, hyperthermen Extremitätenperfusion mit Tumor-Nekrose-Faktor alpha und Melphalan', CHIRURG, Jg. 68, Nr. 9, S. 914-20.

APA

Vancouver

Bibtex

@article{2709dc7f75f84c84903ed11ca7594c95,
title = "Erfassung regionaler und systemischer Toxizit{\"a}t der isolierten, hyperthermen Extremit{\"a}tenperfusion mit Tumor-Nekrose-Faktor alpha und Melphalan",
abstract = "Following isolated limb perfusion (ILP) with TNF alpha and melphalan the damage to muscle tissue and its systemic consequences in terms of myoglobinemia and myoglobinuria as well as the activation of the cytokine cascade were investigated. We measured the compartmental pressure of the limb during and after perfusion and determined the serum changes of myoglobin, creatine kinase (CK), interleukin (IL)-6, IL-1, s-IL-2-receptor, TNF-receptor, and ICAM-1 levels. The compartmental pressure rose significantly during ILP and decreased after reperfusion. Following its course, the decision whether to perform a fasciotomy or not can be more reliably made. Serum myoglobin levels exceeded 200 times normal values and the increase occurred significantly earlier than that of CK, thus enabling judgement of the risk of renal failure (crush kidney syndrome). The elevation of serum IL-1 and IL-6 values correlated with the frequency of cardiopulmonary problems (hyperdynamic shock) and facilitated counter-maneuvers. Our data, although obtained from ILP with TNF alpha, could be used to monitor toxicity also when other drug regimens are administered.",
keywords = "Adolescent, Adult, Aged, Antineoplastic Agents, Alkylating, Chemotherapy, Cancer, Regional Perfusion, Combined Modality Therapy, Compartment Syndromes, Cytokines, Extremities, Female, Follow-Up Studies, Humans, Hyperthermia, Induced, Male, Melanoma, Melphalan, Middle Aged, Myoglobin, Myoglobinuria, Neoplasm Recurrence, Local, Recombinant Proteins, Rhabdomyolysis, Sarcoma, Skin Neoplasms, Soft Tissue Neoplasms, Tumor Necrosis Factor-alpha",
author = "P Hohenberger and J Haier and C Kettelhack and G Schulze and Schlag, {P M}",
year = "1997",
month = sep,
language = "Deutsch",
volume = "68",
pages = "914--20",
journal = "CHIRURG",
issn = "0009-4722",
publisher = "Springer",
number = "9",

}

RIS

TY - JOUR

T1 - Erfassung regionaler und systemischer Toxizität der isolierten, hyperthermen Extremitätenperfusion mit Tumor-Nekrose-Faktor alpha und Melphalan

AU - Hohenberger, P

AU - Haier, J

AU - Kettelhack, C

AU - Schulze, G

AU - Schlag, P M

PY - 1997/9

Y1 - 1997/9

N2 - Following isolated limb perfusion (ILP) with TNF alpha and melphalan the damage to muscle tissue and its systemic consequences in terms of myoglobinemia and myoglobinuria as well as the activation of the cytokine cascade were investigated. We measured the compartmental pressure of the limb during and after perfusion and determined the serum changes of myoglobin, creatine kinase (CK), interleukin (IL)-6, IL-1, s-IL-2-receptor, TNF-receptor, and ICAM-1 levels. The compartmental pressure rose significantly during ILP and decreased after reperfusion. Following its course, the decision whether to perform a fasciotomy or not can be more reliably made. Serum myoglobin levels exceeded 200 times normal values and the increase occurred significantly earlier than that of CK, thus enabling judgement of the risk of renal failure (crush kidney syndrome). The elevation of serum IL-1 and IL-6 values correlated with the frequency of cardiopulmonary problems (hyperdynamic shock) and facilitated counter-maneuvers. Our data, although obtained from ILP with TNF alpha, could be used to monitor toxicity also when other drug regimens are administered.

AB - Following isolated limb perfusion (ILP) with TNF alpha and melphalan the damage to muscle tissue and its systemic consequences in terms of myoglobinemia and myoglobinuria as well as the activation of the cytokine cascade were investigated. We measured the compartmental pressure of the limb during and after perfusion and determined the serum changes of myoglobin, creatine kinase (CK), interleukin (IL)-6, IL-1, s-IL-2-receptor, TNF-receptor, and ICAM-1 levels. The compartmental pressure rose significantly during ILP and decreased after reperfusion. Following its course, the decision whether to perform a fasciotomy or not can be more reliably made. Serum myoglobin levels exceeded 200 times normal values and the increase occurred significantly earlier than that of CK, thus enabling judgement of the risk of renal failure (crush kidney syndrome). The elevation of serum IL-1 and IL-6 values correlated with the frequency of cardiopulmonary problems (hyperdynamic shock) and facilitated counter-maneuvers. Our data, although obtained from ILP with TNF alpha, could be used to monitor toxicity also when other drug regimens are administered.

KW - Adolescent

KW - Adult

KW - Aged

KW - Antineoplastic Agents, Alkylating

KW - Chemotherapy, Cancer, Regional Perfusion

KW - Combined Modality Therapy

KW - Compartment Syndromes

KW - Cytokines

KW - Extremities

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Hyperthermia, Induced

KW - Male

KW - Melanoma

KW - Melphalan

KW - Middle Aged

KW - Myoglobin

KW - Myoglobinuria

KW - Neoplasm Recurrence, Local

KW - Recombinant Proteins

KW - Rhabdomyolysis

KW - Sarcoma

KW - Skin Neoplasms

KW - Soft Tissue Neoplasms

KW - Tumor Necrosis Factor-alpha

M3 - SCORING: Zeitschriftenaufsatz

C2 - 9410682

VL - 68

SP - 914

EP - 920

JO - CHIRURG

JF - CHIRURG

SN - 0009-4722

IS - 9

ER -